These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19564357

  • 1. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
    Michalak TI, Zhang H, Churchill ND, Larsson T, Johansson NG, Oberg B.
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
    [Abstract] [Full Text] [Related]

  • 2. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE, Xiong S, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [Abstract] [Full Text] [Related]

  • 3. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE, Gerin JL, Tennant BC.
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [Abstract] [Full Text] [Related]

  • 4. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC, Korba BE.
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [Abstract] [Full Text] [Related]

  • 5. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE, Suresh M, Li B, Huang X, Yon C, Kallakury BV, Lee KP, Park S, Kim YW, Menne S.
    Cells; 2021 Sep 05; 10(9):. PubMed ID: 34571970
    [Abstract] [Full Text] [Related]

  • 6. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.
    Antimicrob Agents Chemother; 2008 Oct 05; 52(10):3617-32. PubMed ID: 18676881
    [Abstract] [Full Text] [Related]

  • 7. Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Li DH, Brown C, Eisenberg EJ, Cundy KC, Wolfe J, Toole J, Gibbs C.
    Antimicrob Agents Chemother; 2001 Oct 05; 45(10):2740-5. PubMed ID: 11557463
    [Abstract] [Full Text] [Related]

  • 8. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2007 Sep 05; 51(9):3177-84. PubMed ID: 17606676
    [Abstract] [Full Text] [Related]

  • 9. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE, Schinazi RF, Cote P, Tennant BC, Gerin JL.
    Antimicrob Agents Chemother; 2000 Jun 05; 44(6):1757-60. PubMed ID: 10817750
    [Abstract] [Full Text] [Related]

  • 10. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA, Xie H, Wright KN, Hornbuckle WE, Gerin JL, Tennant BC, Hostetler KY.
    Hepatology; 1996 May 05; 23(5):958-63. PubMed ID: 8621175
    [Abstract] [Full Text] [Related]

  • 11. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
    Menne S, Tumas DB, Liu KH, Thampi L, AlDeghaither D, Baldwin BH, Bellezza CA, Cote PJ, Zheng J, Halcomb R, Fosdick A, Fletcher SP, Daffis S, Li L, Yue P, Wolfgang GH, Tennant BC.
    J Hepatol; 2015 Jun 05; 62(6):1237-45. PubMed ID: 25559326
    [Abstract] [Full Text] [Related]

  • 12. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE, Cote P, Hornbuckle W, Tennant BC, Gerin JL.
    Hepatology; 2000 May 05; 31(5):1165-75. PubMed ID: 10796894
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.
    Genovesi EV, Lamb L, Medina I, Taylor D, Seifer M, Innaimo S, Colonno RJ, Standring DN, Clark JM.
    Antimicrob Agents Chemother; 1998 Dec 05; 42(12):3209-17. PubMed ID: 9835516
    [Abstract] [Full Text] [Related]

  • 14. Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B.
    Korolowicz KE, Iyer RP, Czerwinski S, Suresh M, Yang J, Padmanabhan S, Sheri A, Pandey RK, Skell J, Marquis JK, Kallakury BV, Tucker RD, Menne S.
    PLoS One; 2016 Dec 05; 11(8):e0161313. PubMed ID: 27552102
    [Abstract] [Full Text] [Related]

  • 15. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S, Balsitis S, Chamberlain J, Zheng J, Santos R, Rowe W, Ramakrishnan D, Pattabiraman D, Spurlock S, Chu R, Kang D, Mish M, Ramirez R, Li L, Li B, Ma S, Hung M, Voitenleitner C, Yon C, Suresh M, Menne S, Cote P, Delaney WE, Mackman R, Fletcher SP.
    Hepatology; 2021 Jan 05; 73(1):53-67. PubMed ID: 32246499
    [Abstract] [Full Text] [Related]

  • 16. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
    Genovesi EV, Lamb L, Medina I, Taylor D, Seifer M, Innaimo S, Colonno RJ, Clark JM.
    Antiviral Res; 2000 Dec 05; 48(3):197-203. PubMed ID: 11164506
    [Abstract] [Full Text] [Related]

  • 17. The woodchuck model of hepatitis B virus infection.
    Tennant BC, Gerin JL.
    ILAR J; 2001 Dec 05; 42(2):89-102. PubMed ID: 11406711
    [Abstract] [Full Text] [Related]

  • 18. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, Cecchi A, Linsey D, Linzey D, Frick L, Paff MT, Goulding A, Biron K.
    Antimicrob Agents Chemother; 1997 Oct 05; 41(10):2076-82. PubMed ID: 9333028
    [Abstract] [Full Text] [Related]

  • 19. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, Tennant BC, Gerin JL.
    Antivir Ther; 2000 Jun 05; 5(2):95-104. PubMed ID: 10971862
    [Abstract] [Full Text] [Related]

  • 20. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M, Li B, Huang X, Korolowicz KE, Murreddu MG, Gudima SO, Menne S.
    Front Immunol; 2021 Jun 05; 12():745802. PubMed ID: 34671360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.